로딩 중…
지수 로딩 중…
Novartis AG
NVS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$161.47+0.42%
2026-11-02
Financials
Valuation Metrics
Novartis AG's Market Cap is $308.10B. At end of 2025 it was $263.75B. Ranked #41 of 3,116 in US market (top 1%), #21 of 1,644 on NYSE (top 1%), #5 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 2%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $308.10B | US#41/3,116 Sec#5/265 |
| Revenue | $55.63B | US#114/3,116 Sec#7/265 |
| Net Income | $12.76B | US#45/3,116 Sec#4/265 |
| Total Assets | $122.03B | US#147/3,116 Sec#7/265 |
| Net Assets | $41.54B | US#108/3,116 Sec#7/265 |
| Employees | 75,267 | US#170/3,116 Sec#4/265 |
| Value | ||
| P/E | 24.15x | US#1,347/3,116 Sec#38/265 |
| P/B | 7.42x | US#2,470/3,116 Sec#175/265 |
| P/S | 5.54x | US#2,361/3,116 Sec#86/265 |
| EV/EBITDA | 15.70x | US#1,576/3,116 Sec#41/265 |
| FCF Yield | 5.13% | US#1,352/3,116 Sec#41/265 |
| Profitability | ||
| ROE | 30.71% | US#283/3,116 Sec#16/265 |
| ROA | 10.46% | US#456/3,116 Sec#34/265 |
| Op. Margin | 30.54% | US#497/3,116 Sec#27/265 |
| Revenue Growth | 0.81% | US#2,135/3,116 Sec#128/265 |
| Earnings Growth | -6.55% | US#1,386/3,116 Sec#35/265 |
| Financial Health | ||
| Debt Ratio | 192.79% | US#1,746/3,116 Sec#195/265 |
| Total Debt | $49.01B | US#90/3,116 Sec#6/265 |
| FCF | $15.82B | US#44/3,116 Sec#5/265 |
| Cash | $7.62B | US#136/3,116 Sec#5/265 |
| Current Ratio | 0.86x | US#2,430/3,116 Sec#260/265 |
| Net Debt/EBITDA | 1.86x | US#1,280/3,116 Sec#55/265 |
| Dividend | ||
| Div. Yield | 2.95% | US#607/3,116 Sec#9/265 |
| Div. Growth | 3.07% | US#970/3,116 Sec#15/265 |
| Performance | ||
| 1Y Return | 30.44% | US#846/3,116 Sec#92/265 |
| 1M Return | 14.52% | US#681/3,116 Sec#45/265 |
| From 52W High | -5.27% | US#514/3,116 Sec#36/265 |
| 1Y MDD | -18.66% | US#544/3,116 Sec#16/265 |
| Trading | ||
| Volume | 1,451,265 shares | US#848/3,116 Sec#79/265 |
| Trading Value | $234M | US#316/3,116 Sec#17/265 |
| Per Share | ||
| EPS | $6.69 | US#497/3,116 Sec#15/265 |
| BPS | $21.77 | US#1,154/3,116 Sec#25/265 |
Company Info
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.